Literature DB >> 11874855

Development and use of multimeric major histocompatibility complex molecules.

Tim F Greten1, Jonathan P Schneck.   

Abstract

Mesh：

Year:  2002        PMID： 11874855      PMCID： PMC119966          DOI： 10.1128/cdli.9.2.216-220.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  57 in total

1.  Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent.

Authors:  J A Whelan; P R Dunbar; D A Price; M A Purbhoo; F Lechner; G S Ogg; G Griffiths; R E Phillips; V Cerundolo; A K Sewell
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen.

Authors:  T M Fahmy; J G Bieler; M Edidin; J P Schneck
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

3.  TCR avidity: it's not how strong you make it, it's how you make it strong.

Authors:  D H Margulies
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  Cutting edge: lipid raft integrity affects the efficiency of MHC class I tetramer binding and cell surface TCR arrangement on CD8+ T cells.

Authors:  D R Drake; T J Braciale
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

5.  Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cells.

Authors:  A Bonelo; D Valmori; F Triponez; J M Tiercy; G Mentha; J Oberholzer; P Champagne; J F Romero; F Esposito; I Nebié; C Barbey; P Romero; S Herrera; G Corradin; J A López
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

6.  Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.

Authors:  J Chang; A Srikiatkhachorn; T J Braciale
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

7.  Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation.

Authors:  Y Xiong; M A Luscher; J D Altman; M Hulsey; H L Robinson; M Ostrowski; B H Barber; K S MacDonald
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.

Authors:  J E Slansky; F M Rattis; L F Boyd; T Fahmy; E M Jaffee; J P Schneck; D H Margulies; D M Pardoll
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

Review 9.  Assessing CD8 T cell number and dysfunction in the presence of antigen.

Authors:  R M Welsh
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

10.  Quantitative studies on T cell diversity. I. Determination of the precursor frequencies for two types of streptococcus A-specific helper cells in nonimmune, polyclonally activated splenic T cells.

Authors:  K Eichmann; I Falk; I Melchers; M M Simon
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307
View more
  4 in total

1.  Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.

Authors:  Sonja Obermann; Susanne Petrykowska; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  Immunology       Date:  2007-04-30       Impact factor: 7.397

Review 2.  Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.

Authors:  Mathias Oelke; Jonathan P Schneck
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

3.  Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patients.

Authors:  Michael M Woll; Christine M Fisher; Gayle B Ryan; Jennifer M Gurney; Catherine E Storrer; Constantin G Ioannides; Craig D Shriver; Judd W Moul; David G McLeod; Sathibalan Ponniah; George E Peoples
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

4.  MHC-Ig induces memory T cell formation in vivo and inhibits tumour growth.

Authors:  Christian Schütz; Alessia Zoso; Shiwen Peng; Jonathon D Bennett; Jonathan P Schneck; Mathias Oelke
Journal:  Immun Inflamm Dis       Date:  2014-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.